Free Trial

bluebird bio (BLUE) Earnings Date, Estimates & Call Transcripts

$0.97
0.00 (-0.29%)
(As of 05/24/2024 08:49 PM ET)
Skip Charts & View Estimated and Actual Earnings Data

BLUE Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BLUE Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

bluebird bio Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20244($0.69)($0.29)($0.53)
Q2 20244($0.69)($0.31)($0.54)
Q3 20244($0.58)($0.27)($0.47)
Q4 20244($0.50)($0.18)($0.38)
FY 202416($2.46)($1.05)($1.93)
Q1 20253($0.46)($0.25)($0.36)
Q2 20253($0.34)($0.23)($0.30)
Q3 20253($0.36)($0.21)($0.26)
Q4 20253($0.20)($0.07)($0.15)
FY 202512($1.36)($0.76)($1.07)

bluebird bio Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/7/2023Q3 2023($0.69)($0.66)+$0.03($0.66)$13.56 million$12.40 million      
8/8/2023Q2 2023($0.72)($0.67)+$0.05($0.67)$11.30 million$6.90 million      
5/9/2023Q1 2023($0.54)$0.21+$0.75$0.21$26.97 million$2.40 million  
3/29/2023Q4 2022($0.45)$0.38+$0.83$0.38$102.24 million$0.06 million
11/7/2022Q3 2022($1.28)($0.92)+$0.36($0.90)$2.25 million$0.07 million
8/4/2022Q2 2022($1.31)($1.29)+$0.02($1.22)$6.47 million$1.52 million
5/9/2022Q1 2022($1.26)($1.66)($0.40)($1.66)$0.17 million$1.95 million
3/4/2022Q4 2021($1.82)($1.82)-($1.50)$5.72 million$1.61 million
11/5/2021Q3 2021($2.65)($3.16)($0.51)($2.70)$39.07 million$22.70 million    
8/8/2021Q2 2021($3.26)($3.58)($0.32)($3.58)$13.31 million$7.50 million    
5/4/2021Q1 2021($3.02)($3.07)($0.05)($3.07)$10.71 million$12.79 million
2/22/2021Q4 2020($2.96)($3.01)($0.05)($3.01)$15.01 million$10.71 million  
11/9/2020Q3 2020($3.02)($2.94)+$0.08($2.94)$25.47 million$19.27 million    
8/5/2020Q2 2020($2.58)($0.36)+$2.22($0.36)$101.74 million$198.89 million
5/11/2020Q1 2020($4.05)($3.64)+$0.41($3.64)$8.00 million$21.90 million    
2/18/2020Q4($3.79)($4.04)($0.25)($4.04)$8.23 million$10.00 million  
10/31/2019Q3($3.54)($3.73)($0.19)($3.73)$12.47 million$8.91 million
8/1/2019Q2 2019($3.0380)($3.5460)($0.5080)($3.55)$13.13 million$13.30 million

bluebird bio Earnings - Frequently Asked Questions

How much revenue does bluebird bio generate each year?

bluebird bio (NASDAQ:BLUE) has a recorded annual revenue of $3.60 million.

How much profit does bluebird bio generate each year?

bluebird bio (NASDAQ:BLUE) has a recorded net income of -$266.58 million. BLUE has generated -$0.74 earnings per share over the last four quarters.

What is bluebird bio's EPS forecast for next year?

bluebird bio's earnings are expected to grow from ($1.72) per share to ($1.09) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:BLUE) was last updated on 5/27/2024 by MarketBeat.com Staff

From Our Partners